Open Access
BIO Web Conf.
Volume 59, 2023
2023 5th International Conference on Biotechnology and Biomedicine (ICBB 2023)
Article Number 02015
Number of page(s) 4
Section Precision Medicine and Drug Development and Preparation
Published online 08 May 2023
  • Ahmed, Maizbha U, Velkov, Tony, Zhou, Qi Tony, Fulcher, Alex J, Callaghan, Judy, Zhou, Fanfan, . . . Li, Jian. (2019). Intracellular localization of polymyxins in human alveolar epithelial cells. Journal of Antimicrobial Chemotherapy, 74(1), 48–57. [Google Scholar]
  • Lin, Yu-Wei, Aye, Su Mon, Rao, Gauri, Zhou, Qi Tony, Chan, Hak-Kim, & Li, Jian. (2020). Treatment of infections caused by Gram-negative pathogens: Current status on the pharmacokinetics/pharmacodynamics of parenteral and inhaled polymyxins in patients. International Journal of Antimicrobial Agents, 56(6), 106199. [CrossRef] [PubMed] [Google Scholar]
  • Himstedt, Anneke, Borghardt, Jens Markus, & Wicha, Sebastian Georg. (2022). Inferring pulmonary exposure based on clinical PK data: Accuracy and precision of model-based deconvolution methods. Journal of Pharmacokinetics and Pharmacodynamics, 49(2), 135–149. [CrossRef] [PubMed] [Google Scholar]
  • Shetty, Nivedita, Cipolla, David, Park, Heejun, & Zhou, Qi Tony. (2020). Physical stability of dry powder inhaler formulations. Expert Opinion on Drug Delivery, 17(1), 77–96. [CrossRef] [PubMed] [Google Scholar]
  • Xu, You, Harinck, Laure, Lokras, Abhijeet G., Gerde, Per, Selg, Ewa, Sjöberg, Carl-Olof, . . . Foged, Camilla. (2022). Leucine improves the aerosol performance of dry powder inhaler formulations of siRNA-loaded nanoparticles. International Journal of Pharmaceutics, 621, 121758. [CrossRef] [Google Scholar]
  • Zhiling, Yu, Joseph, B., Schwartz, & Edwin, et al. (1996). Five modified numerical deconvolution methods for biopharmaceutics and pharmacokinetics studies. Biopharmaceutics & Drug Disposition, 17(6), 521–540. [CrossRef] [PubMed] [Google Scholar]
  • Bhagwat, S., Schilling, U., Chen, M. J., Wei, X., Delvadia, R., Absar, M., et al. (2017). Predicting pulmonary pharmacokinetics from in vitro properties of dry powder inhalers. Pharmaceutical Research. [Google Scholar]
  • Zhou, Q. T., Morton, D., Yu, H. H., Jacob, J., Wang, J., & Li, J., et al. (2014). Colistin powders with high aerosolisation efficiency for respiratory infection: preparation and in vitro evaluation. Journal of Pharmaceutical Sciences, 102(10), 3736–3747. [Google Scholar]
  • Weber, B., Hochhaus, G. (2013). A pharmacokinetic simulation tool for inhaled corticosteroids. AAPS J. Jan;15(1):159–171. [CrossRef] [Google Scholar]
  • Pulmonary and systemic pharmacokinetics of inhaled and intravenous colistin methanesulfonate in cystic fibrosis patients: targeting advantage of inhalational administration.[J]. Antimicrob Agents Chemother, 2014, 58(5):2570–2579. [CrossRef] [PubMed] [Google Scholar]
  • Lin, Y. W., Zhou, A. Q., Onufrak, B., Wirth, C. V., & Chen, D. K. . (2017). Aerosolized polymyxin b for treatment of respiratory tract infections: determination of pharmacokinetic/pharmacodynamic indices for aerosolized polymyxin b against pseudomonas aeruginosa in a mouse lung infection model. Antimicrobial Agents and Chemotherapy, 61(8). [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.